|
|
||||||||
CUTTING EDGE |

,
,
* Committees on Cancer Biology and
Immunology,
Department of Pathology, and
Department of Medicine, University of Chicago, Chicago, IL 60637
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
It has been appreciated that, following initial TCR-dependent T cell stimulation, a subset of molecules is repositioned to the T cell/Ag-expressing cell (AEC)3 contact site, or immunological synapse (1, 2, 3). Further molecule subpartitioning can occur at the immunological synapse, resulting in what have been termed the central and the peripheral supramolecular activation cluster (cSMAC and pSMAC, respectively). Protein kinase C (PKC)-
is a novel member of the PKC family that is the only PKC isoform to be recruited to the immunological synapse (4), and has been used as a marker for the cSMAC structure (1, 5). Talin, a
-actin binding protein that is associated with integrin signaling complexes (6), has been used as a marker for the pSMAC (1, 3).
Although striking images of cSMAC/pSMAC segregation have been observed in some T cell/AEC model systems, the physiological function of this architecture remains elusive. It has been proposed that immune synapse formation is necessary for agonist-driven signaling (2, 7); however, recent observations have called into question this hypothesis (8, 9). We have recently observed using a CD8+ TCR Tg system that naive T cells become activated, produce IL-2, proliferate, and differentiate into effector cells, all in the absence of detectable cSMAC/pSMAC segregation (5). In as much as effector cells but not naive cells were capable of forming a cSMAC in this model, the question of whether cSMAC formation in effector cells could be linked to other functions specific to effector, but not naive, CD8+ T cells, such as directed cytolytic activity, was raised. This hypothesis was supported by observations of Griffiths and colleagues (3) who reported secretion of cytotoxic granule contents in the vicinity of the cSMAC. In this study, we examined this hypothesis directly. Contrary to expectations, we found no evidence that generation of a cSMAC is required for granule reorientation or cytolytic activity by CD8+ effector T cells.
| Materials and Methods |
|---|
|
|
|---|
All of the mice were housed in the University of Chicago Animal Facility under specific pathogen-free conditions. Animals were used in agreement with the University of Chicago Institutional Animal Care and Use Committee according to the National Institutes of Health guidelines for animal use. 129S6/SvEvTac-Rag2tm1Fwa were serially intercrossed with 2C TCR transgenic mice on the C57BL/6J background to obtain B6;129 2C/RAG2/ mice (herein referred to as 2C/RAG2/) (10). Effector CD8+ T cells were generated as described previously by Cham et al. (11). Briefly, naive T cells were purified by negative selection from the spleens of 2C/RAG2/ mice, and effector cells were generated by coculture of naive cells in vitro with mitomycin C-treated P815.B7-1 cells for two 4-day stimulations.
Immunofluorescence Abs and reagents
The following reagents were used: polyclonal rabbit anti-PKC
and goat anti-talin (Santa Cruz Biotechnology); anti-tubulin mAb (DM1A, Neomarker; Lab Vision); anti-Granzyme A (7.1; generous gift from Markus Simon, Max-Planck-Institute, Freiburg, Germany); and Lysotracker Red DND-99 (Molecular Probes). Secondary Abs conjugated to Texas Red and FITC were all obtained from Jackson ImmunoResearch Laboratories.
Immunofluorescence
To distinguish target cells from T cells, target cells were loaded with the vital dye 7-amino-4-chloromethylcoumarin (CMAC) Cell-Tracker Blue (Molecular Probes) as previously described (12). Targets (1.5 x 105) were mixed with an equal number of Ficoll-Hypaque-purified CD8+ effector T cells in DMEM with 10% FCS, centrifuged at 5000 rpm for 30 s, and incubated for 5 min at 37°C. Supernatants were aspirated, and conjugates were then gently resuspended in serum-free DMEM and plated onto poly-L-lysine (Sigma-Aldrich)-coated slides for two additional minutes before fixation. Slides were fixed in 3% (w/v) paraformaldehyde in PBS for 15 min. Samples were permeabilized in 0.3% (v/v) Triton X-100 (Sigma-Aldrich) in PBS for 10 min, and then rinsed in PBS and blocked in DMEM containing 10% FCS for 5 min. All subsequent Ab incubations were performed in calcium-/magnesium-free Dulbeccos PBS containing 2% FCS. Primary and secondary Abs were applied sequentially for 60 min at room temperature and washed five times with Dulbeccos following each incubation. After fluorochrome labeling, specimens were mounted in Mowiol 488 (Hoechst Celanese), with 10% 1,4-diazobicyclo[2.2.2]octane (Sigma-Aldrich) added as an antifade. Samples were analyzed using a Zeiss Axiovert100 microscope with a 63x oil objective lens. Image capture and deconvolution analysis (where appropriate) was performed using SlideBook software (Intelligent Imaging Innovations). Thirty-two conjugates were scored per condition, and experiments were repeated at least three times. Standard Students t tests were performed when appropriate.
Chromium release assay
Chromium release assays were performed as previously described (13). Briefly, 51Cr-labeled targets (2 x 103) were plated with effector CD8+ T cells at the indicated E:T ratio in a 96-well V-bottom plate (ICN Biomedicals) either in the presence or absence of CTLA4Ig fusion protein (50 µg/ml). After 4 h of incubation at 37°C, 50 µl of supernatant was transferred to a LumaPlate-96 (PerkinElmer Life Sciences) and allowed to dry overnight. Plates were then counted using a TopCount-NXT plate reader (PerkinElmer Life Sciences).
| Results and Discussion |
|---|
|
|
|---|
focusingIn light of recent observations that cSMAC formation could be seen in effector but not naive CD8+ TCR Tg T cells (5), we examined the hypothesis that generation of a cSMAC might be linked to granule-mediated cytolytic activity, which is a function conducted only by effector cells.
Using primed 2C TCR Tg CD8+ effector cells and Ld-expressing P815 cell targets, we first examined the percentage of conjugates that generate a cSMAC and the percentage of conjugates that mobilize cytotoxic granules toward the T cell/target cell interface. Granules were visualized by intracellular staining for granzyme A. As shown in Fig. 1A, PKC
and talin staining successfully distinguished cSMAC/pSMAC segregation in T cell-target cell conjugates. Unconjugated effector CD8+ T cells displayed discrete, punctate staining of intracellular vesicles containing granzyme A in a nonpolarized pattern (Fig. 1B) (14). Effector CD8+ T cells conjugated to P815 cells polarized granzyme A toward the T cell/target cell contact site (Fig. 1B). However, when parallel sets of conjugates were scored for the percentage that formed a cSMAC and the percentage that mobilized cytotoxic granules, there was no statistical association. Whereas 10.6 ± 5.6% of effector cell/target cell conjugates displayed focused PKC
, 82.1 ± 6.9% mobilized cytotoxic granules toward the interface (Fig. 1D) (p = 0.0001).
|
Simultaneous imaging of granule polarization and cSMAC generation
Although scoring independent sets of conjugates for PKC
focusing and granule reorientation provided a statistical indication that cSMAC formation was not required for granule movement, it was desirable to image both events simultaneously in the same T cells. Therefore Lysotracker Red DND-99 (LysoTracker), a cell-permeant dye, which accumulates and fluoresces in acidic compartments in live cells (17), was used as an alternative stain to identify granules. As shown in Fig. 2A, both anti-granzyme A mAb and Lysotracker labeled the same intracellular vesicles.
|
localization was assayable (Fig. 2B). The majority (91.9 ± 2.3%) of conjugated CD8+ T effector T cells with P815 target cells polarized granules toward the contact site. Of these conjugates, PKC
was recruited to the immunological synapse in a diffuse pattern in the vast majority of cases; however, focused PKC
was detected in fewer than 10% of conjugates (Fig. 2C). Thus, granule polarization toward the target cell clearly could occur without a detectable cSMAC. B7-1 costimulation augments cSMAC formation but does not augment granule polarization nor cytolytic activity
We and others (5, 18) have recently observed that B7-1 expression by the target cell increases the fraction of T cells that generate a cSMAC (Fig. 3A). This augmentation was decreased to the level observed with P815 cells in the presence of the B7-1-blocking fusion protein (Fig. 3A). By coculturing T cells with either Lysotracker-labeled P815 or P815.B7-1 targets, we could regulate the degree of cSMAC formation and examine correlation with granule reorientation and cytolysis. Representative images of simultaneous granule reorientation and PKC
localization are depicted in Fig. 3B.
|
to the immunological synapse irrespective of the presence or absence of B7-1 (Fig. 3C). However, only a small fraction of conjugates with polarized granules displayed focused PKC
in the absence of B7-1 (Fig. 3C). The lack of cSMAC formation in T cells that readily polarized lytic granules toward the T cell/target cell interface strongly suggests that granule polarization can occur independently of cSMAC formation in effector CD8+ T cells. Granule polarization toward the immunological synapse has been observed in mutant effector CD8+ T cells incapable of granule secretion (19). Therefore, it was formally possible that there could be discordance between the repositioning of lytic granules to the immunological synapse and the actual exocytosis of these granules into the target cell to induce target cell death. We were unable to visualize directly the granule exocytosis event in our experimental system. Therefore, to address whether the presence of B7-1 influenced the cytolytic potential of effector CD8+ T cells, a 4-h 51Cr-release assay was performed using targets either expressing or lacking B7-1. The presence of B7-1 on target cells did not significantly alter the percentage-specific lysis (Fig. 4), as has been reported previously (20). In addition, kinetic analyses revealed that lysis was not accelerated in the presence of B7-1 (data not shown). Thus, despite markedly increasing the formation of a cSMAC by CD8+ effector cells, B7-1 expression had no impact on cytolytic activity.
|
Our results are supported by other work assessing the number of TCR/peptide-MHC complexes required for cytolysis to occur. Faroudi et al. (21) demonstrated that CD8+ T cells can reorient the MTOC and granules at peptide concentrations that yielded only marginally detectable levels of phosphotyrosine or CD2 enrichment at the CTL-target contact. Furthermore, Purbhoo et al. (9) demonstrated that cytotoxicity could occur at very low peptide-MHC densities, such that three peptide-MHC complexes were sufficient to get target cell killing. This correlates with too few TCRs to detect pSMAC/cSMAC segregation. However, we were careful to note that at higher peptide-MHC densities, stable immunological synapse formation was detectable, and the morphological changes observed in the target cell at these higher peptide-MHC densities were more indicative of perforin-mediated cytotoxicity (9).
The functional significance of the immunological synapse remains elusive. cSMAC/pSMAC segregation appears dispensable for T cell activation (5, 8) and for the execution of T cell function (5, 22). One hypothesis is that the immunological synapse plays a role in the down-regulation and attenuation of T cell signaling (8). Alternatively, the observation that CD28 costimulation potentiates cSMAC formation suggests that the generation of a cSMAC may be reflective of a modulated TCR signal. Additional work will be necessary to distinguish these possibilities.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by National Institutes of Health Grant R01 AI47919. ![]()
2 Address correspondence and reprint requests to Dr. Thomas F. Gajewski, University of Chicago, 5841 South Maryland Avenue, MC2115, Chicago, IL 60637. E-mail address: tgajewsk{at}medicine.bsd.uchicago.edu ![]()
3 Abbreviations used in this paper: AEC, Ag-expressing cell; cSMAC, central supramolecular activation cluster; pSMAC, peripheral supramolecular activation cluster; PKC, protein kinase C; CMAC, 7-amino-4-chloromethylcoumarin; MTOC, microtubule organizing center. ![]()
Received for publication April 8, 2005. Accepted for publication August 8, 2005.
| References |
|---|
|
|
|---|
during T-cell activation. Nature 385:83.-86. [Medline]
within the immunologic synapse. Proc. Natl. Acad. Sci. USA 99:9369.-9373.
production in human CD4+ T cells. J. Immunol. 173:3062.-3072. This article has been cited by other articles:
![]() |
C. Barcia, K. Wawrowsky, R. J. Barrett, C. Liu, M. G. Castro, and P. R. Lowenstein In Vivo Polarization of IFN-{gamma} at Kupfer and Non-Kupfer Immunological Synapses during the Clearance of Virally Infected Brain Cells J. Immunol., February 1, 2008; 180(3): 1344 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pastor, C. G. Vaccaro, A. Minguela, R. J. Ober, and E. S. Ward Analyses of TCR clustering at the T cell-antigen-presenting cell interface and its impact on the activation of naive CD4+ T cells Int. Immunol., November 1, 2006; 18(11): 1615 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Bunnell, A. L. Singer, D. I. Hong, B. H. Jacque, M. S. Jordan, M.-C. Seminario, V. A. Barr, G. A. Koretzky, and L. E. Samelson Persistence of cooperatively stabilized signaling clusters drives T-cell activation. Mol. Cell. Biol., October 1, 2006; 26(19): 7155 - 7166. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barcia, C. E. Thomas, J. F. Curtin, G. D. King, K. Wawrowsky, M. Candolfi, W.-D. Xiong, C. Liu, K. Kroeger, O. Boyer, et al. In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain J. Exp. Med., September 4, 2006; 203(9): 2095 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wiedemann, D. Depoil, M. Faroudi, and S. Valitutti Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses PNAS, July 18, 2006; 103(29): 10985 - 10990. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |